Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
University of Miami AIDS CRS (901)
mi
from
Miami, FL
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
University of Miami AIDS CRS (901)
mi
from
Miami, FL
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
Univ. of South Florida (USF) College of Medicine ATN CRS (33001)
mi
from
Tampa, FL
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
Univ. of South Florida (USF) College of Medicine ATN CRS (33001)
mi
from
Tampa, FL
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
The Ponce de Leon Ctr. CRS (5802)
mi
from
Atlanta, GA
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
The Ponce de Leon Ctr. CRS (5802)
mi
from
Atlanta, GA
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
IHV Baltimore Treatment CRS (4651)
mi
from
Baltimore, MD
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
IHV Baltimore Treatment CRS (4651)
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
201 Johns Hopkins University CRS
mi
from
Baltimore, MD
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
201 Johns Hopkins University CRS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
Cooper Univ. Hosp. CRS (31476)
mi
from
Camden, NJ
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
Cooper Univ. Hosp. CRS (31476)
mi
from
Camden, NJ
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
Columbia Physicians and Surgeons CRS (30329)
mi
from
New York, NY
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
Columbia Physicians and Surgeons CRS (30329)
mi
from
New York, NY
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
Trillium Health ACTG CRS (1108)
mi
from
Rochester, NY
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
Trillium Health ACTG CRS (1108)
mi
from
Rochester, NY
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
University of Rochester Adult HIV Therapeutic Strategies Network CRS (31787)
mi
from
Rochester, NY
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
University of Rochester Adult HIV Therapeutic Strategies Network CRS (31787)
mi
from
Rochester, NY
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
Case CRS (2501)
mi
from
Cleveland, OH
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
Case CRS (2501)
mi
from
Cleveland, OH
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
Metro Health CRS (2503)
mi
from
Cleveland, OH
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
Metro Health CRS (2503)
mi
from
Cleveland, OH
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
Hops. of Univ. of Pennsylvania CRS (6201)
mi
from
Philadelphia, PA
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
Hops. of Univ. of Pennsylvania CRS (6201)
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
The Miriam Hospital ACTG CRS (2951)
mi
from
Providence, RI
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
The Miriam Hospital ACTG CRS (2951)
mi
from
Providence, RI
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
St. Jude Children's Research Hosp. ATN CRS (33016)
mi
from
Memphis, TN
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
St. Jude Children's Research Hosp. ATN CRS (33016)
mi
from
Memphis, TN
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
Peabody Health Center CRS (31443)
mi
from
Dallas, TX
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
Peabody Health Center CRS (31443)
mi
from
Dallas, TX
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
Texas Childrens Hospital ATN CRS (33018)
mi
from
Houston, TX
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
Texas Childrens Hospital ATN CRS (33018)
mi
from
Houston, TX
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
University of Washington AIDS CRS (1401)
mi
from
Seattle, WA
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
University of Washington AIDS CRS (1401)
mi
from
Seattle, WA
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
Puerto Rico-AIDS CRS (5401)
mi
from
San Juan,
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
Puerto Rico-AIDS CRS (5401)
mi
from
San Juan,
Click here to add this to my saved trials
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated:  1/24/2018
Washington U CRS (2101)
mi
from
Saint Louis, MO
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
A Phase 2b, Double-Blind, Placebo-Controlled, Exploratory Randomized Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naïve Patients Infected With R5-Tropic HIV-1
Status: Enrolling
Updated: 1/24/2018
Washington U CRS (2101)
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth
Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth
Status: Enrolling
Updated:  1/25/2018
Ann and Robert H. Lurie Children's Hospital
mi
from
Chicago, IL
Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth
Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth
Status: Enrolling
Updated: 1/25/2018
Ann and Robert H. Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Randomized Trial of an HIV Navigation Program for Early Palliative Care
Randomized Trial of an HIV Navigation Program for Early Palliative Care
Status: Enrolling
Updated:  1/25/2018
Case Western Reserve Univ
mi
from
Cleveland, OH
Randomized Trial of an HIV Navigation Program for Early Palliative Care
Randomized Trial of an HIV Navigation Program for Early Palliative Care
Status: Enrolling
Updated: 1/25/2018
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Reducing HIV Risks in African American Teens
Reducing HIV Risks in African American Teens in High Poverty Urban Settings
Status: Enrolling
Updated:  1/30/2018
Education Development Center, Inc.
mi
from
Newton, MA
Reducing HIV Risks in African American Teens
Reducing HIV Risks in African American Teens in High Poverty Urban Settings
Status: Enrolling
Updated: 1/30/2018
Education Development Center, Inc.
mi
from
Newton, MA
Click here to add this to my saved trials
DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects
DRIVESHAFT : Darunavir/Ritonavir In Virologically-suppressed Experienced Subjects Halving an Antiretroviral by Finetuning Therapy - A Phase IV Randomized, Open-Label Study to Evaluate in HIV-1 Infected , Virologically-suppressed Patients on Regimens With Darunavir 600mg/ Ritonavir 100mg Twice-daily Switching to Darunavir 800mg/ Ritonavir 100mg Once-daily Versus Continuing Darunavir 600mg/ Ritonavir 100mg Twice-daily Containing Regimens
Status: Enrolling
Updated:  1/30/2018
The Ruth M. Rothstein CORE Center
mi
from
Chicago, IL
DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects
DRIVESHAFT : Darunavir/Ritonavir In Virologically-suppressed Experienced Subjects Halving an Antiretroviral by Finetuning Therapy - A Phase IV Randomized, Open-Label Study to Evaluate in HIV-1 Infected , Virologically-suppressed Patients on Regimens With Darunavir 600mg/ Ritonavir 100mg Twice-daily Switching to Darunavir 800mg/ Ritonavir 100mg Once-daily Versus Continuing Darunavir 600mg/ Ritonavir 100mg Twice-daily Containing Regimens
Status: Enrolling
Updated: 1/30/2018
The Ruth M. Rothstein CORE Center
mi
from
Chicago, IL
Click here to add this to my saved trials
HIV Prevention Among Vulnerable Male Youth
Feasibility and Acceptability Trial of Behavioral Group-based HIV Prevention Intervention for Young Men Who Have Sex With Men (YMSM).
Status: Enrolling
Updated:  1/30/2018
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
HIV Prevention Among Vulnerable Male Youth
Feasibility and Acceptability Trial of Behavioral Group-based HIV Prevention Intervention for Young Men Who Have Sex With Men (YMSM).
Status: Enrolling
Updated: 1/30/2018
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID
MND-ADA Transduction of CD34+ Cells From the Bone Marrow Of Children With Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID): Effect of Discontinuation of PEG-ADA and Marrow Cytoreduction With Busulfan
Status: Enrolling
Updated:  2/1/2018
University of California at Los Angeles
mi
from
Los Angeles, CA
MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID
MND-ADA Transduction of CD34+ Cells From the Bone Marrow Of Children With Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency (SCID): Effect of Discontinuation of PEG-ADA and Marrow Cytoreduction With Busulfan
Status: Enrolling
Updated: 2/1/2018
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Risky Sex Prevention Intervention for Middle School Age Minority Girls
A Risky Sex Prevention Intervention for Middle School Age Minority Girls
Status: Enrolling
Updated:  2/2/2018
University of North Carolina at Greensboro
mi
from
Greensboro, NC
A Risky Sex Prevention Intervention for Middle School Age Minority Girls
A Risky Sex Prevention Intervention for Middle School Age Minority Girls
Status: Enrolling
Updated: 2/2/2018
University of North Carolina at Greensboro
mi
from
Greensboro, NC
Click here to add this to my saved trials
Vitamin D Supplementation in HIV Youth
Vitamin D Supplementation and HIV-related Complications in Children and Young Adults
Status: Enrolling
Updated:  2/5/2018
Emory Children's Center
mi
from
Atlanta, GA
Vitamin D Supplementation in HIV Youth
Vitamin D Supplementation and HIV-related Complications in Children and Young Adults
Status: Enrolling
Updated: 2/5/2018
Emory Children's Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Vitamin D Supplementation in HIV Youth
Vitamin D Supplementation and HIV-related Complications in Children and Young Adults
Status: Enrolling
Updated:  2/5/2018
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Vitamin D Supplementation in HIV Youth
Vitamin D Supplementation and HIV-related Complications in Children and Young Adults
Status: Enrolling
Updated: 2/5/2018
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
IGHID 1320 - A Phase I Study to Evaluate the Safety, Immunologic, and Virologic Responses of HIV-1 Antigen Expanded Specific T Cell Therapy (HXTC) as a Therapeutic Strategy in HIV-Infected Individuals Started on Antiretroviral Therapy During Acute and Chronic Infection
Status: Enrolling
Updated:  2/9/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
IGHID 1320 - A Phase I Study to Evaluate the Safety, Immunologic, and Virologic Responses of HIV-1 Antigen Expanded Specific T Cell Therapy (HXTC) as a Therapeutic Strategy in HIV-Infected Individuals Started on Antiretroviral Therapy During Acute and Chronic Infection
Status: Enrolling
Updated: 2/9/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
A Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated Cryptococcal Meningitis
Status: Enrolling
Updated:  2/12/2018
University of Southern California CRS
mi
from
Los Angeles, CA
High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
A Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated Cryptococcal Meningitis
Status: Enrolling
Updated: 2/12/2018
University of Southern California CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
A Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated Cryptococcal Meningitis
Status: Enrolling
Updated:  2/12/2018
Byramjee Jeejeebhoy Medical College (BJMC) CRS
mi
from
Pune,
High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
A Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated Cryptococcal Meningitis
Status: Enrolling
Updated: 2/12/2018
Byramjee Jeejeebhoy Medical College (BJMC) CRS
mi
from
Pune,
Click here to add this to my saved trials
Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy
Immunologic and Virologic Response in HIV Infected Progressors After Infusion of Lymphocytes From HIV Infected "Elite" Long-Term Non-Progressors
Status: Enrolling
Updated:  2/13/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy
Immunologic and Virologic Response in HIV Infected Progressors After Infusion of Lymphocytes From HIV Infected "Elite" Long-Term Non-Progressors
Status: Enrolling
Updated: 2/13/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology
Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology
Status: Enrolling
Updated:  2/13/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology
Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology
Status: Enrolling
Updated: 2/13/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Text Messaging Intervention to Improve HIV Adherence in Rural Drug Users
RCT of a Text Messaging Adherence Assessment & Intervention Tool for Rural HIV+ Drug Users
Status: Enrolling
Updated:  2/13/2018
UVA Infectious Diseases Clinic
mi
from
Charlottesville, VA
Text Messaging Intervention to Improve HIV Adherence in Rural Drug Users
RCT of a Text Messaging Adherence Assessment & Intervention Tool for Rural HIV+ Drug Users
Status: Enrolling
Updated: 2/13/2018
UVA Infectious Diseases Clinic
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Rapid Oral Test for Therapeutic Response in HIV/AIDS Patients
Rapid Oral Test for Therapeutic Response in HIV/AIDS Patients
Status: Enrolling
Updated:  2/13/2018
AIDS Healthcare Foundation
mi
from
Los Angeles, CA
Rapid Oral Test for Therapeutic Response in HIV/AIDS Patients
Rapid Oral Test for Therapeutic Response in HIV/AIDS Patients
Status: Enrolling
Updated: 2/13/2018
AIDS Healthcare Foundation
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prevention of HIV Infection in High-Risk Social Networks of African American Men Who Have Sex With Men (MSM)
Prevention of HIV Infection in High-Risk Social Networks of African American MSM
Status: Enrolling
Updated:  2/13/2018
AIDS TaskForce of Greater Cleveland
mi
from
Cleveland, OH
Prevention of HIV Infection in High-Risk Social Networks of African American Men Who Have Sex With Men (MSM)
Prevention of HIV Infection in High-Risk Social Networks of African American MSM
Status: Enrolling
Updated: 2/13/2018
AIDS TaskForce of Greater Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
Prevention of HIV Infection in High-Risk Social Networks of African American Men Who Have Sex With Men (MSM)
Prevention of HIV Infection in High-Risk Social Networks of African American MSM
Status: Enrolling
Updated:  2/13/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Prevention of HIV Infection in High-Risk Social Networks of African American Men Who Have Sex With Men (MSM)
Prevention of HIV Infection in High-Risk Social Networks of African American MSM
Status: Enrolling
Updated: 2/13/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Enhancement by Poly-ICLC During HIV-1 Infection
Simultaneous Disruption of Latency and Immune Enhancement by Poly-ICLC During HIV-1 Infection
Status: Enrolling
Updated:  2/13/2018
Rockefeller University Hospital
mi
from
New York, NY
Enhancement by Poly-ICLC During HIV-1 Infection
Simultaneous Disruption of Latency and Immune Enhancement by Poly-ICLC During HIV-1 Infection
Status: Enrolling
Updated: 2/13/2018
Rockefeller University Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy
Status: Enrolling
Updated:  2/14/2018
University California Los Angeles, School of Medicine, Pediatric, Infectious Diseases
mi
from
Los Angeles, CA
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy
Status: Enrolling
Updated: 2/14/2018
University California Los Angeles, School of Medicine, Pediatric, Infectious Diseases
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy
Status: Enrolling
Updated:  2/14/2018
Children'S Diagnostic Treatment Center
mi
from
Fort Lauderdale, FL
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy
Status: Enrolling
Updated: 2/14/2018
Children'S Diagnostic Treatment Center
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy
Status: Enrolling
Updated:  2/14/2018
University of Florida - Jacksonville
mi
from
Jacksonville, FL
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy
Status: Enrolling
Updated: 2/14/2018
University of Florida - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy
Status: Enrolling
Updated:  2/14/2018
St. Christopher's Hospital for Children
mi
from
Philadelphia, PA
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy
Status: Enrolling
Updated: 2/14/2018
St. Christopher's Hospital for Children
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy
Status: Enrolling
Updated:  2/14/2018
Hospital del Nino
mi
from
Panama City,
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy
Status: Enrolling
Updated: 2/14/2018
Hospital del Nino
mi
from
Panama City,
Click here to add this to my saved trials
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy
Status: Enrolling
Updated:  2/14/2018
Jeffrey Goodman Special Care Clinic
mi
from
Los Angeles, CA
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy
Status: Enrolling
Updated: 2/14/2018
Jeffrey Goodman Special Care Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy
Status: Enrolling
Updated:  2/14/2018
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children
A Phase III, Randomized, Open-Label Study Comparing the Safety and Efficacy of Switching Stavudine or Zidovudine to Tenofovir Disoproxil Fumarate Versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV-Infected Children Taking Highly Active Antiretroviral Therapy
Status: Enrolling
Updated: 2/14/2018
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
PK and PD Study of Oral F/TAF for HIV Prevention
Exploratory Pharmacokinetic and Pharmacodynamic Study of Oral F/TAF for the Prevention of HIV Acquisition
Status: Enrolling
Updated:  2/16/2018
Magee-Womens Research Institute and Foundation
mi
from
Pittsburgh, PA
PK and PD Study of Oral F/TAF for HIV Prevention
Exploratory Pharmacokinetic and Pharmacodynamic Study of Oral F/TAF for the Prevention of HIV Acquisition
Status: Enrolling
Updated: 2/16/2018
Magee-Womens Research Institute and Foundation
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
PK and PD Study of Oral F/TAF for HIV Prevention
Exploratory Pharmacokinetic and Pharmacodynamic Study of Oral F/TAF for the Prevention of HIV Acquisition
Status: Enrolling
Updated:  2/16/2018
Eastern Virginia Medical School Clinical Research Center
mi
from
Norfolk, VA
PK and PD Study of Oral F/TAF for HIV Prevention
Exploratory Pharmacokinetic and Pharmacodynamic Study of Oral F/TAF for the Prevention of HIV Acquisition
Status: Enrolling
Updated: 2/16/2018
Eastern Virginia Medical School Clinical Research Center
mi
from
Norfolk, VA
Click here to add this to my saved trials
PK and PD Study of Oral F/TAF for HIV Prevention
Exploratory Pharmacokinetic and Pharmacodynamic Study of Oral F/TAF for the Prevention of HIV Acquisition
Status: Enrolling
Updated:  2/16/2018
Profamilia
mi
from
Santo Domingo,
PK and PD Study of Oral F/TAF for HIV Prevention
Exploratory Pharmacokinetic and Pharmacodynamic Study of Oral F/TAF for the Prevention of HIV Acquisition
Status: Enrolling
Updated: 2/16/2018
Profamilia
mi
from
Santo Domingo,
Click here to add this to my saved trials
Medications for Chronic HIV: Education and Collaboration
Implementing Computerized Clinical Assessment of HIV Patient Adherence
Status: Enrolling
Updated:  2/17/2018
VA Greater Los Angeles
mi
from
Los Angeles, CA
Medications for Chronic HIV: Education and Collaboration
Implementing Computerized Clinical Assessment of HIV Patient Adherence
Status: Enrolling
Updated: 2/17/2018
VA Greater Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Medications for Chronic HIV: Education and Collaboration
Implementing Computerized Clinical Assessment of HIV Patient Adherence
Status: Enrolling
Updated:  2/17/2018
VA Boston
mi
from
Boston, MA
Medications for Chronic HIV: Education and Collaboration
Implementing Computerized Clinical Assessment of HIV Patient Adherence
Status: Enrolling
Updated: 2/17/2018
VA Boston
mi
from
Boston, MA
Click here to add this to my saved trials